HEAL
name pending profile ingest
Momentum inputs (comparable managers):
holder breadth -7.1% ·
share flow +16.4% ·
net new positions -7.7%
· formula
Concentrated accumulation: rising shares among fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q4 2025
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Morgan Stanley ✦ | 310.30K | +34.5% | $9.07M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | Daiwa Securities Group Inc. | 161.67K | n/a | $4.72M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Jane Street Group, Llc | 15.38K | n/a | $449,297 | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Raymond James Financial Inc | 9.32K | n/a | $272,255 | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 5 | LPL Financial LLC | 7.72K | n/a | $225,490 | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Osaic Holdings, Inc. | 2.15K | n/a | $62,780 | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 7 | Royal Bank Of Canada | 1.87K | n/a | $55,000 | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Barclays Plc | 1.72K | n/a | $50,279 | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Bank Of America Corp /De/ | 638 | n/a | $18,639 | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 10 | JPMorgan Chase ✦ | 606 | -50.0% | $17,704 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 11 | Bnp Paribas Financial Markets | 499 | n/a | $14,578 | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Rockefeller Capital Management L.P. | 298 | n/a | $8,706 | 0.0% | n/c | 1 | SEC ↗ |
| 13 | UBS Group AG | 57 | n/a | $1,665 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| Citadel Advisors | $215,847 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 29 holders, 358.27K shares, $7.62M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.